- Home
- ESP vs PRLD Comparison
ESP vs PRLD Comparison
Compare ESP & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- PRLD
- Stock Information
- Founded
- ESP 1928
- PRLD 2016
- Country
- ESP United States
- PRLD United States
- Employees
- ESP N/A
- PRLD N/A
- Industry
- ESP Industrial Machinery/Components
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- ESP Technology
- PRLD Health Care
- Exchange
- ESP Nasdaq
- PRLD Nasdaq
- Market Cap
- ESP 84.1M
- PRLD 73.7M
- IPO Year
- ESP N/A
- PRLD 2020
- Fundamental
- Price
- ESP $28.42
- PRLD $1.22
- Analyst Decision
- ESP
- PRLD Strong Buy
- Analyst Count
- ESP 0
- PRLD 2
- Target Price
- ESP N/A
- PRLD $4.50
- AVG Volume (30 Days)
- ESP 16.6K
- PRLD 608.3K
- Earning Date
- ESP 02-10-2025
- PRLD 02-13-2025
- Dividend Yield
- ESP 2.99%
- PRLD N/A
- EPS Growth
- ESP 51.69
- PRLD N/A
- EPS
- ESP 2.46
- PRLD N/A
- Revenue
- ESP $40,611,323.00
- PRLD $3,000,000.00
- Revenue This Year
- ESP N/A
- PRLD N/A
- Revenue Next Year
- ESP N/A
- PRLD N/A
- P/E Ratio
- ESP $11.97
- PRLD N/A
- Revenue Growth
- ESP 14.32
- PRLD N/A
- 52 Week Low
- ESP $20.20
- PRLD $0.80
- 52 Week High
- ESP $33.00
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- ESP 47.73
- PRLD 54.90
- Support Level
- ESP $26.90
- PRLD $0.98
- Resistance Level
- ESP $29.60
- PRLD $1.43
- Average True Range (ATR)
- ESP 1.07
- PRLD 0.13
- MACD
- ESP 0.08
- PRLD -0.01
- Stochastic Oscillator
- ESP 40.43
- PRLD 53.33
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.